<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Cantor Fitzgerald analyst Pablo Zuanic on Friday reiterated a neutral rating on Aurora Cannabis ACB, -1.08% ACB, -1.02% and cut his 12-month price target to C$7.60 from C$10.75 due to reduced sales estimates. The company said it expects to reach positive Ebitda by the first half of fiscal year 2023, but Zuanic said the company remains a long-term turnaround story.
...read full article on Market Watch
